Forbion, Morningside Ventures and Ascendant BioCapital have led a $196m series-A funding round for Dutch clinical-stage biotechnology company NewAmsterdam Pharma (NAP).
Fund focuses on mid-market companies across western Europe, within a range of sectors
Sale ends a five-year holding period for Apax, which acquired a majority stake in Sandaya from Pragma Capital
HopLop is the first investment from the GP's newly launched special situations strategy
Transaction will see Paragon invest in Questel for a minority stake in the IP consultancy firm